Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Low-resource Settings
100%
Population-based Cohort
100%
Vaccine Effectiveness
100%
Methodological Issues
100%
Infant Mortality
60%
Neonatal Infants
60%
Post-neonatal
60%
Prospective Cohort Study
20%
Developing Countries
20%
Sensitivity Analysis
20%
Diarrhea
20%
Post-licensure
20%
Cause of Death
20%
Live Birth
20%
Child Mortality
20%
Disease Burden
20%
Potential Bias
20%
Politicians
20%
Vaccination Status
20%
Large Cohort Study
20%
Population Exposure
20%
Two-site
20%
Vaccine Program
20%
Realist Evaluation
20%
Analytical Approach
20%
Vaccine Implementation
20%
Program Impact
20%
Poor Region
20%
Epidemiological Approach
20%
Rural Malawi
20%
Methodological Decisions
20%
Mortality Surveillance
20%
13-valent Pneumococcal Conjugate Vaccine (PCV13)
20%
Methodological Review
20%
Total Benefit
20%
Size Bias
20%
Power Effect
20%
Real-world Observational Study
20%
Monovalent Rotavirus Vaccine
20%
Three-Domain
20%
Birth-death
20%
Iterative Method
20%
Per-protocol Analysis
20%
Outcome Ascertainment
20%
Mathematics
Effect Size
100%
Live Birth
100%
Indirect Effect
100%
Iterative Process
100%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Infant Mortality
75%
Prospective Cohort Study
25%
Diarrhea
25%
Childhood Mortality
25%
Population Exposure
25%
Pneumococcus Vaccine
25%
Rotavirus Vaccine
25%
Diseases
25%
Vaccination
25%
Biochemistry, Genetics and Molecular Biology
Cohort Study
100%
Infant Mortality
75%
Prospective Cohort Study
25%
Disease Burden
25%
Childhood Mortality
25%
Rotavirus
25%
Population Exposure
25%